Friday, November 22, 2024
HomeTagsMild to Moderate

Mild to Moderate

Lilly’s Bebtelovimab Receives Emergency Use Authorization for Treatment of COVID-19

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates neutralization against the Omicron...

Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has granted...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics